S

Synlogic
D

SYBX

1.44000
USD
0.00
(0.00%)
Market Closed
Volume
0
EPS
-3
Div Yield
-
P/E
-1
Market Cap
16,842,397
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    ACRS
    -0.14500
    (-6.62%)
    2.04500 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    A
    AMRN
    -0.01500
    (-2.88%)
    0.50510 USD
    A
    ARDX
    0.25000
    (5.30%)
    4.96500 USD
    A
    AVDL
    -0.670
    (-5.79%)
    10.910 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    M
    MYGN
    -0.460
    (-2.93%)
    15.230 USD
    More
News

Title: Synlogic

Sector: Healthcare
Industry: Biotechnology
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformativetreatments for serious diseases.